HEADER OXIDOREDUCTASE 02-AUG-11 3ZWS TITLE STRUCTURE OF HUMAN DIHYDROOROTATE DEHYDROGENASE WITH A BOUND TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDROOROTATE DEHYDROGENASE (QUINONE), MITOCHONDRIAL; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 29-395; COMPND 5 SYNONYM: DHODEHASE, DIHYDROOROTATE OXIDASE, DIHYDROOROTATE COMPND 6 DEHYDROGENASE; COMPND 7 EC: 1.3.5.2, 1.3.3.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR P.A.ACKLAM,M.R.PARSONS REVDAT 2 11-JUL-12 3ZWS 1 JRNL REVDAT 1 27-JUN-12 3ZWS 0 JRNL AUTH P.T.P.BEDINGFIELD,D.COWEN,P.A.ACKLAM,F.CUNNINGHAM, JRNL AUTH 2 M.R.PARSONS,G.A.MCCONKEY,C.W.G.FISHWICK,A.P.JOHNSON JRNL TITL FACTORS INFLUENCING THE SPECIFICITY OF INHIBITOR BINDING TO JRNL TITL 2 THE HUMAN AND MALARIA PARASITE DIHYDROOROTATE JRNL TITL 3 DEHYDROGENASES. JRNL REF J.MED.CHEM. V. 55 5841 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22621375 JRNL DOI 10.1021/JM300157N REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.42 REMARK 3 DATA CUTOFF (SIGMA(F)) : NONE REMARK 3 COMPLETENESS FOR RANGE (%) : 99.89 REMARK 3 NUMBER OF REFLECTIONS : 73722 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.16171 REMARK 3 R VALUE (WORKING SET) : 0.16094 REMARK 3 FREE R VALUE : 0.17633 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.0 REMARK 3 FREE R VALUE TEST SET COUNT : 3897 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.600 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.642 REMARK 3 REFLECTION IN BIN (WORKING SET) : 5411 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.96 REMARK 3 BIN R VALUE (WORKING SET) : 0.235 REMARK 3 BIN FREE R VALUE SET COUNT : 261 REMARK 3 BIN FREE R VALUE : 0.243 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2760 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 82 REMARK 3 SOLVENT ATOMS : 255 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.213 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.028 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.30 REMARK 3 B22 (A**2) : 0.30 REMARK 3 B33 (A**2) : -0.45 REMARK 3 B12 (A**2) : 0.15 REMARK 3 B13 (A**2) : 0.00 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.059 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.059 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.034 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 0.962 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.963 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.955 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2895 ; 0.016 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2000 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3937 ; 1.540 ; 2.016 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4852 ; 0.943 ; 3.002 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 375 ; 5.564 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 126 ;35.096 ;23.254 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 501 ;12.171 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ;18.918 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 440 ; 0.094 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3249 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 566 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1789 ; 1.003 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 741 ; 0.274 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2875 ; 1.821 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1106 ; 2.685 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1050 ; 4.553 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 3ZWS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-AUG-11. REMARK 100 THE PDBE ID CODE IS EBI-49246. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-APR-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 77716 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.60 REMARK 200 RESOLUTION RANGE LOW (A) : 37.42 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 5.4 REMARK 200 R MERGE (I) : 0.08 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.30 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.4 REMARK 200 R MERGE FOR SHELL (I) : 0.44 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.40 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.67 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM ACETATE (PH 4.8), REMARK 280 2.4-2.6 M AMMONIUM SULPHATE, 40 MM C11DAO, 20 MM DDAO. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 82.04800 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 41.02400 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 41.02400 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 82.04800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 30 REMARK 465 ALA A 31 REMARK 465 THR A 32 REMARK 465 GLY A 33 REMARK 465 ASP A 34 REMARK 465 GLU A 35 REMARK 465 ARG A 36 REMARK 465 PHE A 37 REMARK 465 TYR A 38 REMARK 465 ALA A 39 REMARK 465 GLU A 40 REMARK 465 PRO A 69 REMARK 465 ARG A 70 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 99 79.39 -116.08 REMARK 500 ARG A 133 10.05 -140.70 REMARK 500 ASP A 190 91.24 -162.83 REMARK 500 TYR A 356 -60.00 -139.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "AB" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 8-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 9-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMN A1397 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ORO A1398 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A1399 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A1400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A1401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AVQ A1402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A1403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A1404 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1D3H RELATED DB: PDB REMARK 900 HUMAN DIHYDROOROTATE DEHYDROGENASE COMPLEXED WITH REMARK 900 ANTIPROLIFERATIVE AGENT A771726 REMARK 900 RELATED ID: 2WV8 RELATED DB: PDB REMARK 900 COMPLEX OF HUMAN DIHYDROOROTATE DEHYDROGENASE WITH THE REMARK 900 INHIBITOR 221290 REMARK 900 RELATED ID: 2B0M RELATED DB: PDB REMARK 900 HUMAN DIHYDROOROTATE DEHYDROGENASE BOUND TO A REMARK 900 NOVEL INHIBITOR REMARK 900 RELATED ID: 1D3G RELATED DB: PDB REMARK 900 HUMAN DIHYDROOROTATE DEHYDROGENASE COMPLEXED WITH BREQUINAR REMARK 900 ANALOG REMARK 900 RELATED ID: 2BXV RELATED DB: PDB REMARK 900 DUAL BINDING MODE OF A NOVEL SERIES OF DHODH REMARK 900 INHIBITORS REMARK 900 RELATED ID: 3ZWT RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN DIHYDROOROTATE DEHYDROGENASE WITH A REMARK 900 BOUND INHIBITOR DBREF 3ZWS A 30 396 UNP Q02127 PYRD_HUMAN 29 395 SEQRES 1 A 367 MET ALA THR GLY ASP GLU ARG PHE TYR ALA GLU HIS LEU SEQRES 2 A 367 MET PRO THR LEU GLN GLY LEU LEU ASP PRO GLU SER ALA SEQRES 3 A 367 HIS ARG LEU ALA VAL ARG PHE THR SER LEU GLY LEU LEU SEQRES 4 A 367 PRO ARG ALA ARG PHE GLN ASP SER ASP MET LEU GLU VAL SEQRES 5 A 367 ARG VAL LEU GLY HIS LYS PHE ARG ASN PRO VAL GLY ILE SEQRES 6 A 367 ALA ALA GLY PHE ASP LYS HIS GLY GLU ALA VAL ASP GLY SEQRES 7 A 367 LEU TYR LYS MET GLY PHE GLY PHE VAL GLU ILE GLY SER SEQRES 8 A 367 VAL THR PRO LYS PRO GLN GLU GLY ASN PRO ARG PRO ARG SEQRES 9 A 367 VAL PHE ARG LEU PRO GLU ASP GLN ALA VAL ILE ASN ARG SEQRES 10 A 367 TYR GLY PHE ASN SER HIS GLY LEU SER VAL VAL GLU HIS SEQRES 11 A 367 ARG LEU ARG ALA ARG GLN GLN LYS GLN ALA LYS LEU THR SEQRES 12 A 367 GLU ASP GLY LEU PRO LEU GLY VAL ASN LEU GLY LYS ASN SEQRES 13 A 367 LYS THR SER VAL ASP ALA ALA GLU ASP TYR ALA GLU GLY SEQRES 14 A 367 VAL ARG VAL LEU GLY PRO LEU ALA ASP TYR LEU VAL VAL SEQRES 15 A 367 ASN VAL SER SER PRO ASN THR ALA GLY LEU ARG SER LEU SEQRES 16 A 367 GLN GLY LYS ALA GLU LEU ARG ARG LEU LEU THR LYS VAL SEQRES 17 A 367 LEU GLN GLU ARG ASP GLY LEU ARG ARG VAL HIS ARG PRO SEQRES 18 A 367 ALA VAL LEU VAL LYS ILE ALA PRO ASP LEU THR SER GLN SEQRES 19 A 367 ASP LYS GLU ASP ILE ALA SER VAL VAL LYS GLU LEU GLY SEQRES 20 A 367 ILE ASP GLY LEU ILE VAL THR ASN THR THR VAL SER ARG SEQRES 21 A 367 PRO ALA GLY LEU GLN GLY ALA LEU ARG SER GLU THR GLY SEQRES 22 A 367 GLY LEU SER GLY LYS PRO LEU ARG ASP LEU SER THR GLN SEQRES 23 A 367 THR ILE ARG GLU MET TYR ALA LEU THR GLN GLY ARG VAL SEQRES 24 A 367 PRO ILE ILE GLY VAL GLY GLY VAL SER SER GLY GLN ASP SEQRES 25 A 367 ALA LEU GLU LYS ILE ARG ALA GLY ALA SER LEU VAL GLN SEQRES 26 A 367 LEU TYR THR ALA LEU THR PHE TRP GLY PRO PRO VAL VAL SEQRES 27 A 367 GLY LYS VAL LYS ARG GLU LEU GLU ALA LEU LEU LYS GLU SEQRES 28 A 367 GLN GLY PHE GLY GLY VAL THR ASP ALA ILE GLY ALA ASP SEQRES 29 A 367 HIS ARG ARG HET FMN A1397 31 HET ORO A1398 11 HET SO4 A1399 5 HET SO4 A1400 5 HET CL A1401 1 HET AVQ A1402 21 HET ACT A1403 4 HET ACT A1404 4 HETNAM FMN FLAVIN MONONUCLEOTIDE HETNAM ORO OROTIC ACID HETNAM SO4 SULFATE ION HETNAM CL CHLORIDE ION HETNAM AVQ 2-[(2,5-DICHLOROBENZYL)SULFANYL]-5-METHYL[1, HETNAM 2 AVQ 2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-OL HETNAM ACT ACETATE ION HETSYN FMN RIBOFLAVIN MONOPHOSPHATE FORMUL 2 FMN C17 H21 N4 O9 P FORMUL 3 ORO C5 H4 N2 O4 FORMUL 4 SO4 2(O4 S 2-) FORMUL 5 CL CL 1- FORMUL 6 AVQ C13 H10 CL2 N4 O S FORMUL 7 ACT 2(C2 H3 O2 1-) FORMUL 8 HOH *255(H2 O) HELIX 1 1 HIS A 41 LEU A 50 1 10 HELIX 2 2 ASP A 51 LEU A 65 1 15 HELIX 3 3 SER A 76 GLU A 80 5 5 HELIX 4 4 ALA A 104 GLY A 112 1 9 HELIX 5 5 PRO A 138 ASP A 140 5 3 HELIX 6 6 GLY A 153 ALA A 163 1 11 HELIX 7 7 ARG A 164 ASP A 174 1 11 HELIX 8 8 ASP A 190 GLY A 203 1 14 HELIX 9 9 PRO A 204 ALA A 206 5 3 HELIX 10 10 GLY A 220 GLN A 225 5 6 HELIX 11 11 GLY A 226 GLY A 243 1 18 HELIX 12 12 ARG A 245 ARG A 249 5 5 HELIX 13 13 THR A 261 GLY A 276 1 16 HELIX 14 14 LEU A 309 THR A 324 1 16 HELIX 15 15 SER A 338 GLY A 349 1 12 HELIX 16 16 TYR A 356 GLY A 363 1 8 HELIX 17 17 PRO A 364 GLN A 381 1 18 HELIX 18 18 GLY A 385 ILE A 390 1 6 HELIX 19 19 GLY A 391 ARG A 395 5 5 SHEET 1 AA 2 VAL A 81 VAL A 83 0 SHEET 2 AA 2 HIS A 86 PHE A 88 -1 O HIS A 86 N VAL A 83 SHEET 1 AB 9 VAL A 92 ILE A 94 0 SHEET 2 AB 9 LEU A 352 LEU A 355 1 O VAL A 353 N GLY A 93 SHEET 3 AB 9 ILE A 330 VAL A 333 1 O GLY A 332 N GLN A 354 SHEET 4 AB 9 GLY A 279 VAL A 282 1 O LEU A 280 N ILE A 331 SHEET 5 AB 9 ALA A 251 ILE A 256 1 O VAL A 254 N ILE A 281 SHEET 6 AB 9 TYR A 208 ASN A 212 1 O LEU A 209 N LEU A 253 SHEET 7 AB 9 LEU A 178 LEU A 182 1 O VAL A 180 N VAL A 210 SHEET 8 AB 9 PHE A 115 VAL A 121 1 O VAL A 116 N GLY A 179 SHEET 9 AB 9 VAL A 92 ILE A 94 1 O ILE A 94 N GLU A 117 SHEET 1 AC 3 VAL A 134 LEU A 137 0 SHEET 2 AC 3 ALA A 142 ASN A 145 -1 O ALA A 142 N LEU A 137 SHEET 3 AC 3 GLY A 303 GLY A 306 -1 O GLY A 303 N ASN A 145 CISPEP 1 GLY A 119 SER A 120 0 7.61 CISPEP 2 ARG A 131 PRO A 132 0 -6.43 CISPEP 3 VAL A 282 THR A 283 0 15.03 SITE 1 AC1 26 ALA A 95 ALA A 96 GLY A 97 LYS A 100 SITE 2 AC1 26 GLY A 119 SER A 120 ASN A 145 TYR A 147 SITE 3 AC1 26 ASN A 181 ASN A 212 LYS A 255 THR A 283 SITE 4 AC1 26 ASN A 284 THR A 285 SER A 305 GLY A 306 SITE 5 AC1 26 LEU A 309 VAL A 333 GLY A 334 GLY A 335 SITE 6 AC1 26 LEU A 355 TYR A 356 THR A 357 ORO A1398 SITE 7 AC1 26 HOH A2214 HOH A2216 SITE 1 AC2 11 LYS A 100 ASN A 145 TYR A 147 GLY A 148 SITE 2 AC2 11 PHE A 149 ASN A 212 SER A 215 ASN A 217 SITE 3 AC2 11 ASN A 284 THR A 285 FMN A1397 SITE 1 AC3 3 ARG A 245 VAL A 247 HIS A 248 SITE 1 AC4 8 ARG A 57 HIS A 101 ASN A 150 HIS A 152 SITE 2 AC4 8 HOH A2004 HOH A2043 HOH A2054 HOH A2060 SITE 1 AC5 3 HIS A 248 ARG A 298 SER A 299 SITE 1 AC6 12 GLN A 47 PRO A 52 ALA A 55 HIS A 56 SITE 2 AC6 12 ALA A 59 PHE A 98 VAL A 134 ARG A 136 SITE 3 AC6 12 TYR A 356 LEU A 359 THR A 360 PRO A 364 SITE 1 AC7 7 LYS A 307 PRO A 308 ASP A 311 THR A 314 SITE 2 AC7 7 GLN A 315 ARG A 318 HOH A2203 SITE 1 AC8 5 ALA A 169 THR A 172 LEU A 205 ASP A 207 SITE 2 AC8 5 HOH A2105 CRYST1 90.720 90.720 123.072 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011023 0.006364 0.000000 0.00000 SCALE2 0.000000 0.012728 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008125 0.00000